Raymond Dwek United Therapeutics Corp (UTHR) insider trading activity

Raymond Dwek is of UNITED THERAPEUTICS Corp. Currently has a direct ownership of 1,750 shares of UTHR, which is worth approximately $509,915. The most recent transaction as insider was on Apr 14, 2021, when has been sold 2,000 shares (Common Stock) at a price of $54.77 per share, resulting in proceeds of $109,540. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.75K

0% 3M change

0% 12M change

Total Value Held $509,915

RAYMOND DWEK Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Apr 14 2021	BUY Exercise of conversion of derivative security	$109,540 $54.77 p/Share	2,000 Added 50.0%	2,000 Common Stock
Apr 07 2021	SELL Sale (or disposition) back to the issuer	$382,200 $191.1 p/Share	2,000 Reduced 100.0%	0 Common Stock
Apr 07 2021	BUY Exercise of conversion of derivative security	$109,540 $54.77 p/Share	2,000 Added 50.0%	2,000 Common Stock
Nov 10 2020	SELL Sale (or disposition) back to the issuer	$278,560 $139.28 p/Share	2,000 Reduced 100.0%	0 Common Stock
Nov 10 2020	BUY Exercise of conversion of derivative security	$96,220 $48.11 p/Share	2,000 Added 50.0%	2,000 Common Stock
Nov 02 2020	SELL Sale (or disposition) back to the issuer	$669,900 $133.98 p/Share	5,000 Reduced 100.0%	0 Common Stock
Nov 02 2020	BUY Exercise of conversion of derivative security	$273,850 $54.77 p/Share	5,000 Added 50.0%	5,000 Common Stock

Raymond Dwek

Silver Spring, MD

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells UTHR shares.

Notify only if

Value

Insider Trading

Get notified when an United Therapeutics Corp insider buys or sells UTHR shares.

Notify only if

Operation

Value

Type

News

Receive news related to UNITED THERAPEUTICS Corp

Track Activities on UTHR

Account